Phase II

A controlled clinical study of a product to identify common short-term side effects, risks associated with a product and, in some cases, a first measurement of potential efficacy. Phase II trials enroll volunteers who have the same characteristics as people who would be enrolled in the later Phase III trials. Phase II trials enroll up to several hundred participants and often have a number of different testing “arms,” or groups.